Explore the current issue of The New England Journal of Medicine (Vol. 394 No. 7).

Feb 4, 2026 · Enlicitide decanoate, an oral proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor, was shown to reduce low-density lipoprotein (LDL) cholesterol levels in a phase 2 trial; …

The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...

Explore the index of articles published by the New England Journal of Medicine, from original research to videos in clinical medicine and more.

Feb 4, 2026 · Explore this issue of The New England Journal of Medicine (Vol. 0 No. 0).

Nov 21, 2025 · Improvements in medical therapy, carotid-artery stenting, and carotid endarterectomy call into question the preferred management of asymptomatic carotid stenosis. Whether adding …

Remote Access FOLLOW US Facebook X Instagram Youtube LinkedIn Bluesky TikTok Threads PUBLICATIONS The New England Journal of Medicine NEJM Clinician NEJM Evidence NEJM AI …

Jan 28, 2026 · The current standard first-line treatment for hormone-receptor–positive, HER2-positive metastatic breast cancer consists of induction chemotherapy, combined with trastuzumab and …

Mar 5, 2025 · Bacterial vaginosis affects one third of reproductive-aged women, and recurrence is common. Evidence of sexual exchange of bacterial vaginosis–associated organisms between …

May 18, 2025 · Nerandomilast (BI 1015550) is an orally administered preferential inhibitor of phosphodiesterase 4B with antifibrotic and immunomodulatory effects. In a phase 2 trial involving …